Nanjing Leads Biolabs Receives FDA IND Approval for LBL-033 Phase I/II Clinical Trial
China-based Nanjing Leads Biolabs Co., Ltd has revealed that it has received Investigational New Drug...
AstraZeneca Weighs Spinning Off China Business to Shield Against Geopolitical Tensions
According to a report from the UK newspaper The Financial Times (FT), AstraZeneca (AZ, NASDAQ:...
TG ImmunoPharma Receives FDA Approval for Phase I Clinical Study of TGI-6 Bispecific Antibody
China-based TG ImmunoPharma Co., Ltd has announced that it has received approval from the US...
IASO Bio Receives FDA IND Approval for IASO-782 for Autoimmune Disorders
China-based IASO Bio has announced that the US Food and Drug Administration (FDA) has approved...
Adicon Holdings Ltd IPO: A Strategic Move for Growth in Diagnostics
Adicon Holdings Ltd (HKG: 9860), a China-based independent clinic laboratory (ICL) service provider, has successfully...
Acotec Scientific Holdings and Boston Scientific Group plc Sign MOU to Broaden Collaboration
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced a memorandum of understanding (MoU) with...
Aosaikang Pharmaceutical’s ASKB589 Shows Promising Results in Solid Tumor Treatment Study
Beijing Aosaikang Pharmaceutical Co., Ltd (SHE: 002755) has revealed the latest results from a Phase...
Jiangsu Hengrui Medicine Cancels Licensing Agreement with Mabworks Citing Market Changes
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) has announced its decision to cancel a...
Roche’s Evrysdi Receives NMPA Approval for Wider SMA Patient Age Range
Swiss pharmaceutical giant Roche (SWX: ROG) has announced that its blockbuster nervous system drug Evrysdi...
MicuRx Pharmaceuticals’ MRX-4/Contezolid Combo Receives Clinical Trial Approvals for Diabetic Foot Infection
Sino-US firm MicuRx Pharmaceuticals Inc. (SHA: 688373) has announced receiving clinical trial approvals for its...
AstraZeneca Enters Three-Year Collaboration with Cholesgen for Metabolic Disease Therapies
UK-based pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) has signed a three-year collaboration agreement with China-based...
BeiGene to Showcase Brukinsa Data at ICML, Highlighting Efficacy in Relapsed Follicular Lymphoma
China-based biopharmaceutical company BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235) has announced that it will...
Fosun Pharma Initiates Phase II Study of HLX26 and Serplulimab Combo for Metastatic CRC
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has announced the initiation of...
CStone’s Sugemalimab Shows Promising Survival Rates in Stage IV NSCLC Treatment
China-based CStone Pharmaceuticals (HKG: 2616) has announced that the prestigious journal Nature Cancer has published...
Takeda and HutchMed’s Elunate Study Results Published in The Lancet
Takeda (TYO: 4502) and HutchMed (China) Ltd (HKG: 0013, NASDAQ: HCM) have announced that the...
Gates Foundation Renews Partnership with Beijing and Tsinghua to Boost Infectious Disease Research
The Bill & Melinda Gates Foundation has announced the renewal of its collaboration with the...
Grifols AS Plans to Sell Stake in Shanghai RAAS Blood Products Co., Ltd for Up to $1.5 Billion
Spain-based Grifols AS (NASDAQ: GRFS), a leading global player in the blood products industry, has...
Sperogenix Therapeutics and LUCA Healthcare Join Forces to Advance Digital Therapy for Myasthenia Gravis
China-based rare disease specialist Sperogenix Therapeutics Limited has entered into a partnership with compatriot firm...
Jiangxi Jemincare’s JYB1907 Receives NMPA Approval for Clinical Study in Solid Tumors
China-based Jiangxi Jemincare Group has announced that it has received approval from the China National...
NMPA Approves Suzhou MicroPort Joint Medical Technology’s Zirconium Niobium Alloy Femoral Head for Hip Replacement
The National Medical Products Administration (NMPA) has granted marketing approval to Suzhou MicroPort Joint Medical...